Bridget M. Ahmann

Partner

bridget.ahmann@FaegreBD.com
Direct: +1 612 766 8055
Minneapolis Office
2200 Wells Fargo Center
90 S. Seventh Street

Minneapolis, Minnesota 55402-3901

Contact Information


bridget.ahmann@FaegreBD.com2200 Wells Fargo Center
90 S. Seventh Street
Minneapolis, Minnesota 55402-3901
T: +1 612 766 8055
F: +1 612 766 1600

Education

University of Minnesota Law School
J.D., magna cum laude, Order of the Coif (1985)
University of North Dakota
B.A., summa cum laude (1982)

Bar Admissions

Minnesota North Dakota

Court Admissions

U.S. Court of Appeals for the Eighth Circuit U.S. District Court for the District of Minnesota

Bridget M. Ahmann

Partner

Bridget Ahmann's practice focuses on product liability and mass torts, with a particular emphasis in pharmaceutical and medical device litigation. A significant portion of her practice has been in the defense of mass torts litigation on a nationwide or regional basis, where she has concentrated on case management of mass torts, factual and expert discovery, and legal strategies for summary resolution. Her role often involves issues related to science, such as expert development or motion practice, or legal defenses, such as class action, medical monitoring or preemption.

Bridget has worked on defense teams in a wide variety of class action, multidistrict and mass tort litigation including anti-psychotic medication, antidepressants, hormone therapy, diet drugs, silicone gel breast implants, orthopedic implants, latex gloves, vaccines, blood factor concentrates, contaminated food products, asbestos and silica.

In addition to the mass tort area, Bridget has represented manufacturers of a wide variety of products including tires, bicycles, lawn mowers, power tools, home appliances, industrial equipment and products, and agricultural equipment in cases involving serious personal injuries and deaths.

Pro Bono

  • Family Law
  • Legal Access Clinic, Hennepin County

Clerkships

  •  U.S. District Court, District of Minnesota, Hon. Paul A. Magnuson, 1985-87

Presentations

  • Defending Liability Claims in Cases Involving Both Innovator and Generic Manufacturers
    American Conference Institute (December 2008)
  • Innovator and Generic Drug Manufacturer Liability
    American Conference Institute webinar (April 2009)
  • The Food, Drug, and Cosmetic Act—Searching for the Crossroads of Safety and Innovation
    Hamline Law Review Symposium, Hamline University, St. Paul (April 2009)
  • Federal Preemption 2007: The Impact of Lohr, Buckman and the FDA Preamble
    Minnesota State Bar Association, Continuing Legal Education (May 2007)
  • Medical Monitoring: Avoiding Class Certification
    American Conference Institute, New York (April 2002)
  • A Test of Our Own Medicine: Hot Topics and Emerging Trends in Medical Device and Drug Product Cases
    Minnesota State Bar Association, Continuing Legal Education (November 2002)
  • Federal Preemption After Lohr
    Minnesota Institute of Legal Education (September 2000)

Legal Updates

  • We're Not in Kansas Anymore, Toto: Product Liability Biologics and Biosimilars
    For the Defense (August, 2011)
  • Name Brand Exposure for Generic Drug Use:  Prescription for Liability
    Hamline Law Review, Volume 32, Number 3 (Summer 2009)
  • The Use of Settlement Classes in Mass Tort Product Liability
    Hamline Law Review (1994)

Related Practices

Class Actions
Drug & Device Litigation
Litigation & Advocacy
Mass Tort Litigation
Product Liability Litigation
Toxic Tort Litigation

Related Industries

Health Care
Life Sciences
Manufacturing & Industrials

Education

University of Minnesota Law School
J.D., magna cum laude, Order of the Coif (1985)
University of North Dakota
B.A., summa cum laude (1982)

Legal Updates

07-September-2011 - We're Not in Kansas Anymore, Toto: Product Liability Biologics and Biosimilars
11-May-2011 - Judge Rules for Indicted GlaxoSmithKline Attorney – and the Protection of Attorney-Client Privilege
31-March-2011 - Judge Dismisses – Without Prejudice – Bellwether Indictment of GSK Attorney
17-November-2010 - The Stevens Indictment: A Sea Change or a Tempest in a Teapot?
27-July-2010 - Last Call For Minn. Forum Shoppers
02-December-2009 - Levine Goes Generic: Eighth Circuit Weighs In on Preemption and Innovator Liability
08-October-2009 - FDA Provides Draft Guidance on Risk Evaluation and Mitigation Strategies
13-November-2008 - Could Preemption Rulings for Generic Manufacturers Be Bitter Pill for Name-Brand Manufacturers?

News

03-May-2010 - Bridget Ahmann and Erin Verneris Recognized for Legal Writing Excellence
19-March-2009 - Bridget Ahmann to Speak at Hamline Law Review Symposium on the FDCA

Bar Admissions

Minnesota
North Dakota

Court Admissions

U.S. Court of Appeals for the Eighth Circuit
U.S. District Court for the District of Minnesota

Events

26-April-2010 - Levine and Beyond: The Changing Landscape of Preemption and Innovator Liability

Representative Matters

Thompson v. American Tobacco Company et al.
In re Salmonella Litigation
Toxic Torts—Asbestos

Copyright © 2000-2012 Faegre Baker Daniels LLP. All Rights Reserved.